UNSPSC 51284035: Minocycline hydrochloride

This classification denotes a tetracycline antibiotic with the molecular formula C23H27N3O7.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0020414E5U, chemically known as 7-dimethylamino-6-demethyl-6-deoxytetracycline, hcl but more generally known as minocycline hydrochloride, which bears US NIH Compound Identifier 5281093. European Medicines Agency schedules Minocycline hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03304MIG.

UNSPSC 51284035 Minocycline hydrochloride, a Commodity code, sits within a pharmaceutical procurement category that state and local governments use to classify individual pharmaceutical products and active ingredients. However, the recent opportunities posted under this code do not align with minocycline hydrochloride specifically; instead, they reflect broader pharmaceutical and medical supply procurement across state health agencies, counties, and municipalities. The work being solicited includes generic pharmaceuticals and OTC products through cooperative purchasing vehicles, naloxone and drug deactivation systems for community health initiatives, medical and first aid supplies for emergency response, and direct-to-manufacturer prescription programs. Issuing bodies include state health and human services commissions, county health departments, municipal fire departments, and multistate cooperative purchasing alliances. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) and the Texas Health and Human Services Commission appear as recent buyers, alongside Seminole County, Florida and the City of Tampa, indicating that procurement under this code spans state-level agencies, regional health authorities, and local government.

Recent activity concentrates in the South and Upper Midwest. The Minnesota Multistate Cooperative Purchasing Alliance posted an RFP (S1070000015802) on January 20, 2026, with a March 26, 2026 response deadline for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local facilities, including Oregon; the contract is scheduled to be effective July 1, 2026. Seminole County, Florida issued an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline. The City of Tampa's Purchasing Department posted an invitation to bid (26P00145) on March 25, 2026, for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with a March 13, 2026 deadline and an estimated contract value of $700,000.00; this solicitation carries a small local business enterprise set-aside with a 5% bid discount not to exceed $10,000. The Texas Health and Human Services Commission issued an RFI (HHS0017013) on April 3, 2026, to gather market intelligence on direct-to-manufacturer prescription programs for self-insured health plans and state agencies.